Artwork

Content provided by Mayo Clinic. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mayo Clinic or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Genes and Your Health Series: Harnessing the Power of T-Cells for the Treatment of Cancer and Immune Related Diseases

39:54
 
Share
 

Manage episode 484148868 series 1324703
Content provided by Mayo Clinic. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mayo Clinic or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Host: Denise M. Dupras, M.D., Ph.D.

Guest: Saad J. Kenderian, M.B., Ch.B.

Dr. Saad Kenderian discusses the use of CAR-T cell therapy, a groundbreaking treatment that genetically modifies a patient's T-cells to target and destroy cancer cells, particularly in blood cancers like leukemia and lymphoma. He highlights the importance of identifying eligible patients, monitoring treatment response, and applying genomics to guide the future of personalized cancer immunotherapy.

Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts

  continue reading

596 episodes

Artwork
iconShare
 
Manage episode 484148868 series 1324703
Content provided by Mayo Clinic. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mayo Clinic or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Host: Denise M. Dupras, M.D., Ph.D.

Guest: Saad J. Kenderian, M.B., Ch.B.

Dr. Saad Kenderian discusses the use of CAR-T cell therapy, a groundbreaking treatment that genetically modifies a patient's T-cells to target and destroy cancer cells, particularly in blood cancers like leukemia and lymphoma. He highlights the importance of identifying eligible patients, monitoring treatment response, and applying genomics to guide the future of personalized cancer immunotherapy.

Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts

  continue reading

596 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Listen to this show while you explore
Play